LEEF

Leef Brands Inc.

8 filings tracked

healthcarecannabis manufacturingMICRO (<$300M)

Signal Magnitude Chart

bullish

bearish

neutral

Signal Timeline

bullishMay 6

Gross margins expanded from 22% to 49% due to wholesale pivot.

margin expansion

90%

neutralMay 6

Raised $4.5 million through preferred and common share issuances.

capital raise

60%

bearishMay 6

Reported a net loss of $426,253 despite positive operating income.

earnings miss

40%

bullishMay 6

Converted $10.7 million of convertible debentures into equity.

debt restructure

70%

bullishMay 6

Gross margins expanded from 22% to 49% due to wholesale pivot.

margin expansion

90%

neutralMay 6

Raised $4.5 million through preferred and common share issuances.

capital raise

60%

bearishMay 6

Reported a net loss of $426,253 despite positive operating income.

earnings miss

40%

bullishMay 6

Converted $10.7 million of convertible debentures into equity.

debt restructure

70%

bullishMay 6

Gross margins expanded from 22% to 49% due to wholesale pivot.

margin expansion

90%

neutralMay 6

Raised $4.5 million through preferred and common share issuances.

capital raise

60%

bearishMay 6

Reported a net loss of $426,253 despite positive operating income.

earnings miss

40%

bullishMay 6

Converted $10.7 million of convertible debentures into equity.

debt restructure

70%

bullishMay 6

Gross margins expanded from 22% to 49% due to wholesale pivot.

margin expansion

90%

neutralMay 6

Raised $4.5 million through preferred and common share issuances.

capital raise

60%

bearishMay 6

Reported a net loss of $426,253 despite positive operating income.

earnings miss

40%

bullishMay 6

Converted $10.7 million of convertible debentures into equity.

debt restructure

70%

bullishMay 6

Gross margins expanded from 22% to 49% due to wholesale pivot.

margin expansion

90%

neutralMay 6

Raised $4.5 million through preferred and common share issuances.

capital raise

60%

bearishMay 6

Reported a net loss of $426,253 despite positive operating income.

earnings miss

40%

bullishMay 6

Converted $10.7 million of convertible debentures into equity.

debt restructure

70%

bullishMay 6

Gross margins expanded from 22% to 49% due to wholesale pivot.

margin expansion

90%

neutralMay 6

Raised $4.5 million through preferred and common share issuances.

capital raise

60%

bearishMay 6

Reported a net loss of $426,253 despite positive operating income.

earnings miss

40%

bullishMay 6

Converted $10.7 million of convertible debentures into equity.

debt restructure

70%

bullishMay 6

Gross margins expanded from 22% to 49% due to wholesale pivot.

margin expansion

90%

neutralMay 6

Raised $4.5 million through preferred and common share issuances.

capital raise

60%

bearishMay 6

Reported a net loss of $426,253 despite positive operating income.

earnings miss

40%

bullishMay 6

Converted $10.7 million of convertible debentures into equity.

debt restructure

70%

bullishMar 26

Gross margins increased from 27% to 30% due to vertical integration.

margin expansion

70%

bullishMar 26

Converted significant convertible debentures into equity in December 2025.

debt restructure

60%

bearishMar 26

Heavy issuance of common shares and warrants to fund operations and settle debt.

dilution risk

80%

neutralMar 26

Closed $4.5 million equity financing with Mindset Capital LLC in March 2026.

capital raise

50%

Filing History

10-QMay 6, 2026

The Q1 2026 filing reveals a company at a critical crossroads, having successfully optimized its unit economics but failing to achieve overall corporate stability. The shift to wholesale concentrates has proven to be a winning operational strategy, as evidenced by the swing to positive operating income and a significant jump in gross margins. However, these operational wins are currently being neutralized by a legacy of debt, derivative volatility, and the oppressive tax realities of the cannabis industry. Investors are left to weigh a genuine operational turnaround against a fragile balance sheet. While the conversion of debt to equity and the recent capital raise provide temporary breathing room, the persistent net losses and negative equity suggest that Leef is still in a fight for survival. The ultimate success of the pivot will depend on whether the company can maintain its 49% margins while scaling production and navigating the looming threat of its uncertain tax positions.

10-KMar 26, 2026

The 10-K reveals a company in a race against time to scale its vertical integration before its liquidity expires. While the growth in revenue to $34.8 million and the margin expansion from the Salisbury Canyon Ranch are positive operational signals, they are currently overshadowed by a legacy of debt and the crushing weight of federal tax laws. The shift toward a B2B model is the correct strategic move for the California market, but the execution is hampered by a precarious cash position. Investors are essentially betting on the successful scale-up of the remaining 122.9 licensed acres at the Ranch. If Leef can achieve the projected 40-60% reduction in biomass costs, it may reach a sustainable cash-flow positive state. However, until the company can prove it can generate organic cash flow without constant equity infusions or related-party loans, it remains a speculative play on the structural transformation of the cannabis supply chain.